Placeholder

PharmaCase

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 37. Category: .

Product Description

Making a Case For Rebranding
The Rebranding of a Brander

Healthcare advertising agencies, among their many strategic and creative services, excel at branding or rebranding pharmaceutical products, devices, diagnostics, and corporate identities for their clients. Harder to do is to apply those same skills to themselves.
When CommonHealth made the bold move to redefine its image within the industry, it called upon Enterprise IG, which has strong capabilities and a rich heritage in global corporate and consumer branding, to help create a new look and focused mission: “Collaborative Velocity.”
“It’s very hard for companies to undergo a rebranding process for themselves; too often people can’t see the forest for the trees,” says Scott Lerman, CEO and president of Enterprise IG, Americas. “Having a third party helps a company look objectively at where it’s been and where it’s headed. Examining what is relevant and having a focused guide through the process is important whether a company is a branding company or a beverage company.”
CommonHealth’s brand history as a pharmaceutical and healthcare advertising agency extends back 12 years…

Sidebar:
Enterprise IG’s branding Model

Experts on this Topic
Matt Giegerich, CEO, CommonHealth; Scott Lerman, CEO and President, Enterprise IG, Americas; Will Ayres, Managing Director for Creative Services, Enterprise IG

FEEDBACK